rs4760619
Positions:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001354735.1(PFKM):c.-114A>T variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.134 in 702,158 control chromosomes in the GnomAD database, including 7,409 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.12 ( 1392 hom., cov: 32)
Exomes 𝑓: 0.14 ( 6017 hom. )
Consequence
PFKM
NM_001354735.1 5_prime_UTR
NM_001354735.1 5_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.318
Genes affected
PFKM (HGNC:8877): (phosphofructokinase, muscle) Three phosphofructokinase isozymes exist in humans: muscle, liver and platelet. These isozymes function as subunits of the mammalian tetramer phosphofructokinase, which catalyzes the phosphorylation of fructose-6-phosphate to fructose-1,6-bisphosphate. Tetramer composition varies depending on tissue type. This gene encodes the muscle-type isozyme. Mutations in this gene have been associated with glycogen storage disease type VII, also known as Tarui disease. Alternatively spliced transcript variants have been described.[provided by RefSeq, Nov 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 12-48106148-A-T is Benign according to our data. Variant chr12-48106148-A-T is described in ClinVar as [Benign]. Clinvar id is 1239017.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.224 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PFKM | NM_001354735.1 | c.-114A>T | 5_prime_UTR_variant | 1/26 | NP_001341664.1 | |||
PFKM | NM_001354736.1 | c.-173A>T | 5_prime_UTR_variant | 1/26 | NP_001341665.1 | |||
PFKM | NM_001354737.1 | c.-173A>T | 5_prime_UTR_variant | 1/25 | NP_001341666.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PFKM | ENST00000546755.5 | c.-173A>T | 5_prime_UTR_variant | 1/5 | 4 | ENSP00000450173 | ||||
PFKM | ENST00000549366.5 | c.-43A>T | 5_prime_UTR_variant | 1/7 | 4 | ENSP00000449622 | ||||
PFKM | ENST00000552792.5 | c.-173A>T | 5_prime_UTR_variant | 1/6 | 4 | ENSP00000448940 |
Frequencies
GnomAD3 genomes AF: 0.118 AC: 17879AN: 152150Hom.: 1391 Cov.: 32
GnomAD3 genomes
AF:
AC:
17879
AN:
152150
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.131 AC: 16903AN: 129454Hom.: 1399 AF XY: 0.128 AC XY: 9037AN XY: 70788
GnomAD3 exomes
AF:
AC:
16903
AN:
129454
Hom.:
AF XY:
AC XY:
9037
AN XY:
70788
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.139 AC: 76327AN: 549890Hom.: 6017 Cov.: 0 AF XY: 0.135 AC XY: 40156AN XY: 297686
GnomAD4 exome
AF:
AC:
76327
AN:
549890
Hom.:
Cov.:
0
AF XY:
AC XY:
40156
AN XY:
297686
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.117 AC: 17873AN: 152268Hom.: 1392 Cov.: 32 AF XY: 0.114 AC XY: 8468AN XY: 74462
GnomAD4 genome
AF:
AC:
17873
AN:
152268
Hom.:
Cov.:
32
AF XY:
AC XY:
8468
AN XY:
74462
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
371
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 23, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at